Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q4 2022 Earning

Operator: Greetings, and welcome to the Navidea Biopharmaceuticals Fourth Quarter Earnings Call and Business Update. . It is now my pleasure to introduce to you, Dr.

Related Keywords

India , Canada , Texas , United States , Israel , Boston , Massachusetts , China , Alex Cappello , Lymphoseek Europe , Kim Scott , Edward English , Joe Meyer , Joseph Meyer , Michael Rosol , Health Photo , National Cancer Institute On Unsplash , Society Of Nuclear Medicine , Trademark Office , Navidea Biopharmaceuticals Inc , American College Of Rheumatology , Cardinal Health , Texas Court , University Of Alabama At Birmingham , Navidea Biopharmaceuticals , Call Transcript March , Chief Medical , Vice Chair , Vice President , Erika Eves , American College , National Cancer Institute , Nuclear Medicine , Molecular Imaging , Journal Molecular Imaging , Tumor Myeloid Directed Therapy Summit , Annual Meeting , United States Patent , Compositions And Methods For Altering Macrophage , Automation Stocks , Buy Now , Copper Stocks ,